Agilon Health, Inc.
AGL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $780,835 | $5,131,908 | $6,587,606 | $10,802,565 |
| - Cash | $188,231 | $107,570 | $497,070 | $1,040,039 |
| + Debt | $43,963 | $52,309 | $43,482 | $48,401 |
| Enterprise Value | $636,567 | $5,076,647 | $6,134,018 | $9,810,927 |
| Revenue | $6,060,530 | $4,316,363 | $2,388,220 | $1,521,494 |
| % Growth | 40.4% | 80.7% | 57% | – |
| Gross Profit | $4,841 | $69,670 | $111,360 | $65,744 |
| % Margin | 0.1% | 1.6% | 4.7% | 4.3% |
| EBITDA | -$218,186 | -$167,643 | -$72,414 | -$362,160 |
| % Margin | -3.6% | -3.9% | -3% | -23.8% |
| Net Income | -$260,151 | -$262,596 | -$106,553 | -$406,487 |
| % Margin | -4.3% | -6.1% | -4.5% | -26.7% |
| EPS Diluted | -0.63 | -0.64 | -0.26 | -1.09 |
| % Growth | 1.6% | -146.2% | 76.1% | – |
| Operating Cash Flow | -$57,777 | -$156,199 | -$130,808 | -$148,159 |
| Capital Expenditures | -$13,251 | -$30,815 | -$32,661 | -$13,426 |
| Free Cash Flow | -$71,028 | -$187,014 | -$163,469 | -$161,585 |